While some patients may experience benefits at lower doses, clinical evidence shows the 2.4mg dose provides maximum weight loss
Proteomic analyses further suggest that gene expression changes related to oxidative stress (GPX1, superoxide dismutase 1), metabolism (ACACA, GAPDH), placentation (PGF, VEGF-A), and stem cell differentiation (POU5F1, SOX2) may underlie the observed improvement in embryo quality (Marinaro et al., 2018
Guidelines and Recommendations Regulatory status: Not licensed for use in pregnancy (FDA, EMA)
Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity
What a course looks like Session length: usually around 20 to 30 minutes